Uncategorized

4. Hypertension is the most common medical

4. Hypertension is the most common medical problem post-transplantation. The apparent cause of this complication has been associated with which of the following drugs? Steroids / prednisone Cyclosporine Mycophenolate mofetil Calcium channel blockers 5. Which are the following are acceptable agents to replace calcineurin inhibitors after transplantation? Belatacept Methotrexate Alemtuzumab Mycophenolate mofetil . Calcineurin inhibitors seem to be associated with lowering which electrolyte level? Potassium Magnesium Sodium Calcium 2. An example of a monoclonal antibody used in solid organ transplantation to control allograft rejection is: Rapamycin Tacrolimus Anti-thymocyte globulin Alemtuzemab 6. Leukopenia and GI disturbances are seen commonly with which antimetabolite agent? Azathioprine Rapamycin Alemtuzemab Mycophenolate mofetil 7. How are therapeutic drug levels of Tacrolimus monitored? Random level Two hour trough Twelve hour trough Two hour peak 8. What medication is given to patients that have had a solid organ transplant for prevention of allograft rejection? Antiviral Antifungal Calcineurin inhibitor Monoclonal antibodies 9. Which of the following combination of medicines represent the classic and most often used triple-drug maintenance immunosuppression regimen? Cyclosporine, azathioprine, methylprednisolone Tacrolimus, azathioprine, prednisone Cyclosporine, everolimuys, methylprednisolone Tacrolimus, mycophenolate mofetil, prednisone 10. Which of the following immunosuppressive agents is NOT recommended for use after heart transplantation? Tacrolumus Cyclosporine Everolimus Azathioprine . Which specific food product affects the absorption of the calcineurin inhibitors? Pomegranate Oranges Grapefruit Both a and c SCIENCE HEALTH SCIENCE NURSING EMS 209

 
******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."